For pediatric cancers, data from St Jude Children’s Research Hospital PeCan genomics data portal show that only 1 % of pediatric cancers have activating PIK3CA mutations, with pediatric high-grade gliomas being the only diagnosis with 10 % or higher PIK3CA mutation frequency (McLeod et al., 2021). This evidence concerns the gene PIK3CA and central nervous system cancer.